Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mary Ann Picard"'
Autor:
Eric Nehl, Stacy Heilman, David Ku, David Gottfried, Sarah Farmer, Robert Mannino, Erika Tyburski, Julie Sullivan, Allison Suessmith, Leda Bassit, Janet Figueroa, Anna Wood, Traci Leong, Anuradha Rao, Beverly Rogers, Robert Jerris, Sunita Park, Mark Gonzalez, Jennifer Frediani, Claudia Morris, Joshua Levy, Nils Schoof, Maud Mavigner, John Roback, Kristen Herzegh, Natia Saakadze, Jess Ingersoll, Narayana Cheedarla, Andrew Neish, Bradley Hanberry, Christopher Porter, Annette Esper, Russell Kempker, Paulina Rebolledo, Pamela McGuinness, Frederick Balagadde, Rebecca Gore, Ainat Koren, Nira Pollock, Eugene Rogers, Karl Simin, Nathaniel Hafer, Mary Ann Picard, Chiara Ghezzi, David McManus, Bryan Buchholz, Christina Rostad, Viviana Claveria, Thanuja Ramachandra, Yun F. Wang, CaDeidre Washington, Cheryl Stone, Mark Griffiths, Ray Schinazi, Ann Chahroudi, Miriam Vos, Oliver Brand, Greg Martin, Wilbur Lam
Publikováno v:
IEEE Open Journal of Engineering in Medicine and Biology, Vol 2, Pp 142-151 (2021)
Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the “RADxSM Tech Test Verification Core” and it
Externí odkaz:
https://doaj.org/article/97dd1f4fe14142b5900fb67b6edd4cb6
Autor:
Nathaniel Hafer, Bryan Buchholz, Denise Dunlap, Brennan Fournier, Scott Latham, Mary Ann Picard, Steven Tello, Laura Gibson, Craig M. Lilly, David D. McManus
Publikováno v:
Journal of Clinical and Translational Science, Vol 5 (2021)
The commercialization of medical devices and biotechnology products is characterized by high failure rates and long development lead times particularly among start-up enterprises. To increase the success rate of these high-risk ventures, the Universi
Externí odkaz:
https://doaj.org/article/a5ba1334a08741329526dd314d4c0549
Autor:
Robert C. Jerris, Greg S. Martin, Joshua M. Levy, Stacy Heilman, Sarah Farmer, Robert G. Mannino, Pamela D McGuinness, Christina A. Rostad, CaDeidre Washington, John D. Roback, Andrew S. Neish, Maud Mavigner, Claudia R. Morris, Erika A. Tyburski, Leda Bassit, Anuradha Rao, David D. McManus, Kristen Herzegh, Jennifer K. Frediani, Karl Simin, Wilbur A. Lam, Nils Schoof, Mary Ann Picard, Traci Leong, Thanuja Ramachandra, Eugene Rogers, Nathaniel Hafer, Jess M. Ingersoll, Yun F. Wang, Julie Sullivan, Miriam B. Vos, Oliver Brand, Ray Schinazi, Mark D. Gonzalez, David N. Ku, Russell R. Kempker, Viviana Claveria, Beverly Barton Rogers, Annette M. Esper, Janet Figueroa, Frederick Balagadde, Allison Suessmith, Ann Chahroudi, Paulina A. Rebolledo, David S. Gottfried, Cheryl Stone, Rebecca Gore, Anna Wood, Bradley S. Hanberry, Narayana Cheedarla, Bryan Buchholz, Christopher C. Porter, Eric J. Nehl, Sunita Park, Mark D. Griffiths, Nira R. Pollock, Chiara E. Ghezzi, Ainat Koren, Natia Saakadze
Publikováno v:
Ieee Open Journal of Engineering in Medicine and Biology
IEEE Open Journal of Engineering in Medicine and Biology, Vol 2, Pp 142-151 (2021)
IEEE Open Journal of Engineering in Medicine and Biology, Vol 2, Pp 142-151 (2021)
Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the “RADxSM Tech Test Verification Core” and it
Autor:
Brennan Fournier, David D. McManus, Laura Gibson, Steven Tello, Scott Latham, Denise R. Dunlap, Bryan Buchholz, Nathaniel Hafer, Mary Ann Picard, Craig M. Lilly
Publikováno v:
Journal of Clinical and Translational Science
The commercialization of medical devices and biotechnology products is characterized by high failure rates and long development lead times particularly among start-up enterprises. To increase the success rate of these high-risk ventures, the Universi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c1b6ec931000b6ad5a12c0dc64a0e8
https://zenodo.org/record/6402762
https://zenodo.org/record/6402762
Autor:
Bryan Buchholz, Eugene Rogers, Emily Ensom, Timothy P. Fitzgibbons, David D. McManus, Eric Y. Ding, Ainat Koren, Nathaniel Hafer, Carl W. Lawton, Mary Ann Picard, Denise R. Dunlap, Craig M. Lilly
Publikováno v:
Curr Opin Biomed Eng
Recent advancements in point-of-care technologies have transformed care for patients with heart, lung, blood, and sleep disorders by providing rapid, cost-effective, and accessible solutions to challenges in the detection and management of many healt